Zdrowie i gospodarka · 5.01.1999
Draft Guidance for Industry on Bioanalytical Methods Validation for Human Studies; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Bioanalytical Methods Validation for Human Studies.'' This draft guidance provides assistance to sponsors and applicants of investigational new drug applications (IND's), new drug applications (NDA's), abbreviated new drug applications (ANDA's), and supplements, in developing validation information for bioanalytical methods used in human clinical pharmacology, bioavailability, and bioequivalence studies. This draft guidance does not cover analytical methods used for nonhuman pharmacology/toxicology studies, chemistry, manufacturing, and controls information, or in vitro dissolution studies.